Why don't we call it what it is? It's a cartel

The discussion highlights concerns that AI companies are pushing narratives about AI's dangers to advocate for regulation, potentially creating a cartel-like environment. This is compared to the infant formula market, where strict FDA regulations and import rules led to an oligopoly of four companies. When Abbott's Sturgis plant closed in 2022, the market broke due to the lack of legal outside competition, demonstrating how high regulatory barriers can protect domestic players and limit market access.

This analysis uniquely draws a parallel between the current AI regulation debate and the 2022 infant formula shortage, unlike other discussions that focus solely on AI's immediate risks.